Sahajanand Medical Technologies’ IPO is scheduled to open for subscription on October 15, 2026. According to its Red Herring Prospectus (RHP), the ₹475.48 crore issue is entirely an offer for sale (OFS) of 1.38 crore equity shares.

The IPO will remain open until October 19, 2026. The basis of allotment is expected to be finalised on October 21, 2026, and the shares are tentatively scheduled to be listed on the BSE and NSE on October 23, 2026.

Sahajanand Medical Technologies IPO - Issue Details

Issue Type: Book Built Issue (OFS only)
Total Issue Size: Up to ₹475.48 crore
Fresh Issue: Not Applicable
Offer for Sale (OFS): Up to ₹475.48 crore
Face Value: ₹1 per equity share
Price Band: ₹327 to ₹344 per share
Lot Size: 43 shares
Minimum Investment Amount (Retail Investor): ₹14,792 (43 shares at the upper price)
Listing: BSE, NSE
Book Running Lead Managers: Motilal Oswal Investment Advisors Limited, Avendus Capital Private Limited, HSBC Securities and Capital Markets (India) Private Limited, Nuvama Wealth Management Limited
Registrar: MUFG Intime India Private Limited

Sahajanand Medical Technologies IPO Timeline (Tentative)

The expected IPO schedule is as follows:

Event	Date
Subscription Opening Date	15 October 2026
Subscription Closing Date	19 October 2026
Basis of Allotment Date	21 October 2026
Refund Initiation Date	22 October 2026
Credit of Shares	22 October 2026
Listing on BSE and NSE	23 October 2026

Note: The allotment and listing dates are tentative and may be revised.

Explore other Upcoming IPOs on BSE and NSE.

Sahajanand Medical Technologies IPO Category-wise Investment Limits

The application size for each category is as follows -

Category	Investment Range
Qualified Institutional Buyers (QIBs)	Not more than 50% of the Net Issue
Non-Institutional Investors (NIIs)	Not less than 15% of the Net Issue
Retail Individual Investors (RII)	Not less than 35% of the Net Issue

The minimum investment amount for each category, based on the upper price band of ₹344 per share, is as follows -

Investor Category	Lots	Shares	Investment Amount (Approx.)
Retail (Minimum)	1	43	₹14,792
Retail (Maximum)	13	559	₹1,92,296
sNII (Minimum)	14	602	₹2,07,088
bNII (Minimum)	68	2924	₹10,05,856

About Sahajanand Medical Technologies Limited

Founded in 2001, Sahajanand Medical Technologies is a research and development-driven medical devices company. It develops technologically advanced products for vascular and structural heart interventions, including coronary stents, coronary balloons, transcatheter aortic valve implantation (TAVI) devices and occluders.

The company also offers renal stents and peripheral drug-coated balloons (DCBs). The company had a presence in 77 countries in FY2026 and 65 countries in the three months ended June 30, 2026, including India.

Key Financial Highlights

Particulars	For the three month period ended June 30, 2026 (in ₹ crore)	FY26 (in ₹ crore)	FY25 (in ₹ crore)
Revenue from operations	351.67	1,210.50	1,024.88
EBITDA	48.58	170.65	128.02
Profit After Tax (PAT)	15.09	69.08	25.15